BASE
Device
NUVASIVE, INC.
Total Payments
$4.5M
Transactions
816
Doctors
373
Companies
3
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $59,808 | 26 | 9 |
| 2023 | $882,217 | 12 | 9 |
| 2022 | $819,215 | 20 | 6 |
| 2021 | $123,585 | 37 | 24 |
| 2020 | $909,479 | 63 | 56 |
| 2019 | $104,731 | 204 | 135 |
| 2018 | $1.0M | 219 | 126 |
| 2017 | $586,876 | 235 | 136 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $4.4M | 59 | 96.4% |
| Unspecified | $121,110 | 27 | 2.7% |
| Food and Beverage | $33,913 | 701 | 0.8% |
| Consulting Fee | $3,800 | 2 | 0.1% |
| Travel and Lodging | $1,805 | 26 | 0.0% |
| Education | $833.00 | 1 | 0.0% |
Payments by Type
General
$4.4M
789 transactions
Research
$121,110
27 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Prospective, Multicenter Study Evaluating the Safety and Performance of Interbody Implants for the Treatment of Patients With Degenerative Conditions of the thoracic and/or lumbar spine | NuVasive, Inc. | $51,157 | 0 |
| A prospective, multicenter study evaluating the safety and performance of interbody implants for the treatment of patients with degenerative conditions of the thoracic and/or lumbar spine | NuVasive, Inc. | $40,263 | 0 |
| A prospective, multicenter study evaluating the safety and performance of interbody implants for the treatment of patients with degenerative conditions of the thoracic and/or lumbar spine | Globus Medical, Inc. | $25,936 | 0 |
| A prospective, multicenter study evaluating the safety and performance of interbody implants for the treatment of patients with degenerative conditions of the thoracic and/or lumbar spine (Enrolling by invitation) | NuVasive, Inc. | $2,755 | 0 |
| NUVA.LIB1119: A prospective, multicenter study evaluating the safety and performance of interbody implants for the treatment of patients with degenerative conditions of the thoracic and/or lumbar spine | NuVasive, Inc. | $1,000 | 0 |
Top Doctors Receiving Payments for BASE — Page 4
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Orthopaedic Surgery | Oklahoma City, OK | $150.57 | 1 |
| , D.O | Neurological Surgery | Chicago, IL | $150.26 | 1 |
| , M.D | Surgery | Elmhurst, IL | $150.26 | 1 |
| , M.D | Surgery | Boca Raton, FL | $149.70 | 1 |
| , MD | Neurological Surgery | Altoona, PA | $147.58 | 2 |
| , M.D | Internal Medicine | Worcester, MA | $146.33 | 2 |
| , MD | Orthopaedic Surgery of the Spine | Gilbert, AZ | $144.31 | 1 |
| , MD | Neurological Surgery | Staten Island, NY | $142.73 | 1 |
| , MD | Neurological Surgery | Los Angeles, CA | $142.38 | 1 |
| , M.D | Neurological Surgery | Scottsdale, AZ | $142.38 | 1 |
| , MD | Orthopaedic Surgery of the Spine | San Diego, CA | $141.30 | 1 |
| , M.D | Orthopaedic Surgery | Houston, TX | $140.34 | 1 |
| , MD | Vascular Surgery | Gainesville, GA | $140.00 | 1 |
| , MD | Neurological Surgery | Washington, DC | $139.77 | 2 |
| , M.D | Neurological Surgery | Washington, DC | $139.77 | 2 |
| , M.D | Vascular Surgery | New York, NY | $138.40 | 1 |
| , M.D., INC | Orthopaedic Surgery of the Spine | Chicago, IL | $137.70 | 4 |
| , MD, PC | Orthopaedic Surgery of the Spine | Edinburg, TX | $135.77 | 3 |
| , MD | Orthopaedic Surgery | Scottsdale, AZ | $131.37 | 3 |
| , MD | Orthopaedic Surgery | Atlanta, GA | $130.41 | 1 |
| , M.D | Orthopaedic Surgery of the Spine | New Orleans, LA | $130.41 | 1 |
| , M.D | Neurological Surgery | Phoenix, AZ | $130.10 | 2 |
| , M.D | Orthopaedic Surgery | Lexington, KY | $129.84 | 1 |
| , M.D | Orthopaedic Surgery of the Spine | Florence, SC | $127.99 | 1 |
| Justin Singer | — | Grand Rapids, MI | $126.09 | 1 |
Ad
Manufacturing Companies
- NuVasive, Inc. $3.9M
- NUVASIVE, INC. $586,876
- Globus Medical, Inc. $59,808
Product Information
- Type Device
- Total Payments $4.5M
- Total Doctors 373
- Transactions 816
About BASE
BASE is a device associated with $4.5M in payments to 373 healthcare providers, recorded across 816 transactions in the CMS Open Payments database. The primary manufacturer is NUVASIVE, INC..
Payment data is available from 2017 to 2024. In 2024, $59,808 was paid across 26 transactions to 9 doctors.
The most common payment nature for BASE is "Royalty or License" ($4.4M, 96.4% of total).
BASE is associated with 5 research studies, including "A Prospective, Multicenter Study Evaluating the Safety and Performance of Interbody Implants for the Treatment of Patients With Degenerative Conditions of the thoracic and/or lumbar spine" ($51,157).